BACKGROUND: Studies using puri®ed enzyme preparations, placental microsomes or cell lines have shown that certain phytoestrogens can inhibit the enzymes that convert androgens to estrogens, namely aromatase and 17b-hydroxysteroid dehydrogenase (HSD) type 1 and type 5. The study aim was to investigate the effects of selected phytoestrogens on aromatase and 17b-HSD type 1 activity in primary cultures of human granulosa-luteal (GL) cells. METHODS AND RESULTS: GL cells, cultured for 48 h in medium containing 5% fetal calf serum and for a further 24 h in serum-free medium with or without hFSH or hCG, were exposed to steroid substrates during the last 1±4 h of the experiment. The production of progesterone in the presence of pregnenolone or estradiol synthesis from androstenedione, estrone or testosterone showed dose-and time-dependent increases. Whilst hCG priming had no effect on progesterone production, FSH priming induced mean 68 and 56% increases in the production of estradiol from androstenedione (A-dione) and estrone respectively, but had no signi®cant effect on the metabolism of testosterone to estradiol. None of the phytoestrogens investigated had any acute effects on enzyme activity. In contrast, when GL cells were exposed to the compounds for 24 h prior to exposure to steroid substrates for 4 h, 10 mmol/l apigenin and zearalenone signi®cantly inhibited aromatase activity, whilst biochanin A and quercetin had no effect. None of the phytoestrogens inhibited FSH-induced 17b-HSD type 1 activity, and only quercetin signi®cantly inhibited progesterone production. CONCLUSIONS: The inability of phytoestrogens to acutely inhibit steroidogenic enzymes in human GL cells (as has been shown in cell-free models) suggests that they are either rapidly metabolized to relatively inactive compounds or that the high enzyme activity in human GL cells masks any inhibitory effects of the compounds at the concentration tested.
Introduction
Phytoestrogens are plant-derived, non-steroidal compounds that bind to the estrogen receptor (ER) and can induce estrogen-dependent gene transcription (Kuiper et al., 1998) . They are diphenolic substances with structural similarity to estrogen, and can be divided into three main classes:
avanoids; coumestans; and lignans. The group of¯avanoids includes the¯avanones,¯avones and iso¯avones, and these are found in almost all plant families in leaves, stems, roots, owers and seeds (Mazur and Adlercreutz, 2000) . Most avanoids in plants are present as glycosides but they are hydrolysed in the human gastrointestinal tract to biologically active aglycones (Setchell, 1998) .
Whilst relatively little is known about the absorption, metabolism and bioavailability of various phytoestrogens, on a high soy diet or a vegetarian diet, mean plasma concentrations of the various phytoestrogens that have been measured can range from 100 nmol/l to 1 mmol/l (Mazur and Aldercreutz, 2000) . These are concentrations at which phytoestrogens have been shown to have estrogenic effects in vitro (Zava and Duwe, 1997; Maggiolini et al., 2001) . In this respect, soy is being heavily promoted as a natural alternative to hormone replacement therapy.
There is, however, a paradox. Both epidemiological studies (Aldercreutz, 1998; Barnes, 1998) and laboratory investigations (Barnes, 1997) have suggested that dietary compounds may have a major protective effect against post-menopausal breast cancer. Thus, the markedly reduced incidence of breast cancer seen amongst many Asian populations compared with women in Northern Europe and America has been attributed to their diets that are rich in soy products (Aldercreutz, 1998) . These contain high concentrations of conjugated iso¯avones that are thought to have a protective role in breast cancer by acting as weak estrogens or anti-estrogens by competing with endogenous estrogens for binding to the ER.
There is, however, increasing evidence that phytoestrogens may bind to aromatase and/or 17b-hydroxysteroid dehydrogenase (HSD) and thereby reduce the availability of these enzymes for the production of estrogen from androgen precursors and/or the production of estradiol from weak estrogens (Kao et al., 1998; Ma Èkela È et al., 1998; Le Bail et al., 2000) . In breast tissue of post-menopausal women these enzymes are responsible for the local production of estrogens from circulating adrenal androgens (Simpson et al., 2000) .
Previous studies investigating the effects of phytoestrogens on steroidogenic enzyme activity have typically been carried out on puri®ed or recombinant enzyme preparations, placental microsomes or breast cancer cell lines (Ma Èkela È et al., 1998; Le Bail et al., 2000; Krazeisen et al., 2001) . These studies showed that the concentrations inducing a 50% inhibition of enzyme activity (IC 50 ) of the most potent phytoestrogens investigated were generally between 1 and 20 mmol/l. Thus, the purpose of the present study was to establish an experimental protocol that would allow an investigation of the effects of phytoestrogens on aromatase and 17b-HSD type 1 in primary cultures of human cells. The phytoestrogens investigated were twō avones (apigenin and quercetin), an iso¯avone (biochanin A) and the mycotoxin, zearalenone. These compounds have been shown to have relatively potent effects on aromatase and/or 17b-HSD compared with other phytoestrogens (Le Bail et al., 1998; Jeong et al., 1999; Krazeisen et al., 2001) , although their reported potency varies according to the experimental model employed.
Materials and methods

Granulosa-luteal cells
Granulosa-luteal cells were obtained from the Assisted Conception Units at St George's Hospital and King's College Hospital, London, with signed consent of the patients. They were processed within 2 to 5 h of oocyte retrieval, depending on their source. After washing, the cells were puri®ed on a 60% Ficoll gradient and cultured in a 250 ml volume in 96-well culture plates. For the initial experiments, cells were cultured at a concentration of~3Q10 5 cells/ml (Figures 1 and 2 ) and subsequently at a lower concentration of 10 5 cells/ml. The culture medium was DMEM containing 2 mmol/l glutamate, 100 IU/ml penicillin and 100 mg/ml streptomycin (Sigma, Poole, Dorset, UK).
For the`acute' experiments, cells were cultured for 48 h in medium supplemented with 5% fetal calf serum (FCS) and a further 24 h without FCS but with or without 5 ng/ml hFSH, as appropriate. Fresh serum-free medium plus steroid substrates with or without test compounds were added for the last 4 h of culture. This was the period during which estradiol or progesterone production was measured.
For the`chronic' experiments, the protocol was identical except that the cells were exposed to phytoestrogens for 24 h prior to their 4 h exposure to steroid substrates with or without test compounds. For the time-course studies, 25 ml of medium was taken at 1 and 2 h and the volume replaced with fresh medium. The dilution factor was taken into account in the analysis of the data.
At the end of the experiment, media samples were taken and stored at ±20°C and viability of cells was routinely tested either with the Trypan blue exclusion test or with Almar blue (Serotec, Oxford, UK) according to the manufacturer's instructions. This is a non-toxic REDOX indicator that provides a measure of mitochondrial activity and has been found to be more sensitive than the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] assay, particularly when relatively small numbers of cells are being assayed.
Drugs
The following drugs were used in these experiments: apigenin (4¢,5,7-trihydroxy¯avone), biochanin A (4¢methoxy-5,7-dihydroxyiso¯a-vone), quercetin (3,3¢, 4¢,5,7, pentahydroxy¯avone), zearalenone, androstenedione, 4-hydroxyandrostene-3,17-dione (4OH-A), estrone, pregnenolone, testosterone, human FSH (hFSH) and recombinant hCG (rhCG). hFSH and rhCG were kindly supplied by The National Hormone and Pituitary Agency, Torrance, CA, USA; all other drugs were supplied by Sigma UK. All steroids were initially dissolved in ethanol and diluted appropriately with culture medium before being stored as stock solutions. Stock solutions were then further diluted with medium for each experiment and added to cultures in 10 ml volumes to give the desired ®nal concentration. Controls were performed to ensure that the maximum volume of ethanol diluent (1 ml) did not affect cellular responses.
Steroid assays
Progesterone and estradiol samples were measured in duplicate using a direct radioimmunoassay (RIA) kit (ICN Pharmaceuticals Ltd, Basingstoke, UK) according to the manufacturer's instructions. All drugs used in these experiments were tested for their possible crossreactivity with the anti-sera used, but none was detected. The cross- Figure 1 . Combined data of nine individual experiments with triplicate observations, showing the mean concentration of estradiol (E 2 ) synthesized over a 4 h period using 10 ±7 mol/l androstenedione (A-dione), estrone (E 1 ) or testosterone (TEST) as substrates for steroid synthesis. Cells, at a concentration of 3Q10 5 cells/ml were cultured for 48 h in the presence of 5% fetal calf serum, for 24 h in serum-free medium, either with (hatched bars) or without (open bars) 5 ng/ml hFSH, and for a ®nal 4 h in fresh medium but in the presence of 10 ±7 mol/l substrates as indicated. Data represent mean T SEM. *, P < 0.001 compared with paired control values without hFSH priming (Student's t-test).
reactivity of the progesterone anti-serum with 20a-dihydroprogesterone, 17a-hydroxyprogesterone and pregnenolone was 5.4, 0.6 and 0.4% respectively, and that with the estradiol anti-serum with estrone, estriol, progesterone and testosterone and androstenedione was 20, 1.5, <0.01, <0.01 and <0.01% respectively. Inter-and intra-assay coef®cients of variation were respectively 6.2 and 3.0% for the progesterone assay, and 9.1 and 5.2% for the estrogen assay. For each experiment, the cross-reactivity of estrone with the estradiol antibody was monitored by incubating the appropriate concentration of estrone in culture medium without GL cells for 4 h. The mean estradiol concentration measured in the`blank' wells was subtracted from the appropriate experimental measurements. When 10 mmol/l estrone was added to the cultures the cross-reactivity was >20% and thus these results were excluded.
Statistical analysis
Data shown represent mean T SEM of triplicate cultures obtained from at least three independent experiments, and n = the total number of individual observations. When comparing several groups of data, statistical differences were obtained with an analysis of variance, followed by Gabriel's test. A Student's t-test was used to test signi®cance between two groups of data.
Results
The combined results of 12 individual experiments showed that FSH priming signi®cantly increased the synthesis of estradiol from androstenedione and estrone, but had no effect on estradiol synthesis when testosterone was used as a substrate (Figure 1) In the absence of a steroid substrate, basal estradiol production over a 4 h period was either undetectable or was <50 pmol/l compared with progesterone production that was between 350 and 1300 nmol/l. In three individual experiments, the production of estradiol in the presence of increasing concentrations of the three substrates showed a linear dose- Estradiol (E 2 ) and progesterone concentrations in the culture medium after a 4 h incubation with (a) testosterone, (b) androstenedione, (c) estrone and (d) pregnenolone. Cells, at a concentration of 3Q10 5 cells/ml were cultured for 48 h in the presence of 5% fetal calf serum, for 24 h in serum-free medium, with or without 5 ng/ml hFSH, and for a ®nal 4 h in fresh medium but in the presence of 10 ±9 to 10 ±5 substrates as indicated. Data represent mean T SEM of three individual experiments each with triplicate wells. *, P < 0.001 compared with the corresponding values in the absence of FSH (Student's t-test).
dependent relationship (Figure 2a±c ). This was not observed with progesterone production in the presence of pregnenolone, and only the highest concentration of pregnenolone 10 mmol/l signi®cantly increased progesterone production (Figure 2d ). Priming with rhCG had no effect on progesterone synthesis.
The time course of the conversion of the various substrates showed that between 1 and 2 h there was no marked increase in either estradiol or progesterone production, but between 2 and 4 h there was a marked and signi®cant increase in steroid production (Figure 3a and b) . It was thus established that a 24-h exposure to FSH followed by a 4-h exposure to steroid substrates at a dose of 100 nmol/l was a suitable protocol for investigating estradiol production.
To test the assumption that the experimental protocol was providing data on the activity of steroidogenic enzymes, the effects of a well-established aromatase inhibitor 4OH-A were investigated (Figure 4 ). This showed a selective and signi®cant inhibition of estradiol production from either androstenedione or testosterone, both of which require aromatase. In contrast, 4OH-A did not inhibit the conversion of estrone to estradiol that only requires 17b-HSD type 1 activity and, interestingly, there was a modest, but signi®cant, increase in estradiol production in the presence of this aromatase inhibitor.
Apigenin signi®cantly inhibited estradiol production from testosterone, and whilst the mean concentration of estradiol produced from the metabolism of either estrone or androstenedione were reduced, results were not statistically signi®cant (Figure 5a) . A different picture was seen when GL cells were exposed to apigenin for 24 h prior to testing enzyme activity. In this case, estradiol synthesis was markedly reduced irrespective of the steroid substrate (Figure 5a ). The other¯avone, quercetin, had no signi®cant effects on estradiol production from any of the three substrates, irrespective of whether cells were exposed either acutely (4 h) or chronically (24 h) to these phytoestrogens (Figure 5b) . However, unlike the other phytoestrogens investigated, quercetin signi®cantly inhibited progesterone synthesis (Figure 6 ). Exposure of GL cells to the iso¯avone biochanin A for 24 h prior to testing enzyme activity reduced the mean concentration of estradiol produced from all three substrates, but results were not signi®cant (Figure 7a ). Exposure of GL cells to zearalenone for 24 h induced a marked reduction in aromatase activity as evidenced by signi®cant reductions in estradiol production from androstenedione and testosterone but without effect the production of estradiol from estrone ( Figure 7b ). Viability studies run routinely at the end of every chronic experiment showed that none of the phytoestrogens reduced cell viability (Table I) .
Discussion
The results of the present study have shown that there is a doseand time-dependent conversion of androstenedione, testosterone and estrone to estradiol over a 4 h period, and that the aromatase inhibitor, 4OH-A (Devoto et al., 1991) inhibited the production of estradiol from androstenedione and testosterone Figure 5 . Acute and chronic effects of apigenin (a) and quercetin (b) on the synthesis of estradiol (E 2 ) from 100 nmol/l androstenedione (Adione), estrone (E 1 ) or testosterone (TEST). For the acute experiments, GL cells, cultured at a concentration of 10 5 cells/ml, were primed with 5 ng/ml hFSH for 24 h prior to the addition of fresh medium and steroid substrates for 4 h with or without 10 mmol/l apigenin or quercetin. For the chronic experiments, cells were exposed to FSH and the phytoestrogens for 24 h prior to the addition of fresh medium, compounds and steroid substrates for the last 4 h. Data represent mean T SEM of three to four individual experiments (triplicate observations); *, P < 0.01 compared with control (Con) values in the absence of apigenin (Student's t-test). Figure 6 . Chronic effects of apigenin (Api), quercetin (Quer), biochanin A (Bio-A) and zearalenone (Zeal) on progesterone production. GL cells, at a concentration of 10 5 cells/ml were cultured for 48 h in the presence of 5% fetal calf serum and then exposed to phytoestrogens for 24 h prior to the addition of 100 nmol/l pregnenolone plus phytoestrogens in fresh medium. Samples were collected after 4 h. Data represent mean T SEM of three to four individual experiments (triplicate observations); *, P < 0.01 compared with control (Con) values in the absence quercetin (Student's t-test). Phytoestrogens, aromatase and 17b-HSD as predicted. The GL-cell conversion of testosterone to estradiol was inhibited by a mean of 62%, whilst the conversion of androstenedione to estradiol was inhibited by a mean of 88%. There is no apparent reason why 4OH-A should be more potent in inhibiting the metabolism of A-dione to estradiol compared with testosterone to estradiol, nor why the conversion of estrone to estradiol should be signi®cantly enhanced in the presence of 4OH-A. There could be some product inhibition or local feedback regulation of enzyme activity. In this respect, it is interesting to note that low concentrations of estradiol can dose-dependently inhibit the conversion of estrone sulphate to estradiol in MCF-7 breast cancer cells (Pasqualini and Chetrite, 2001) Several previous studies have shown that GL cells obtained from natural cycles are sensitive to FSH, but that those obtained from stimulated cycles are insensitive (Bergh et al., 1991; Mason et al., 1993; Lambert et al., 1995; Foldesi et al., 1998) . It has been reported that a long pre-incubation period of 72 h followed by exposure to FSH for 4±6 days increased basal estradiol production in GL cells in the absence of any androgenic substrate, but in the presence of testosterone FSH had no effect on estradiol production. More recently, it has been reported that GL cells exposed to FSH for 24 h dosedependently increased estradiol synthesis from testosterone over a 2 h period (Lambert et al., 2000) . In the present study, using a protocol similar to that used by Lambert and colleagues, no increase in aromatase activity (as assessed by the conversion of testosterone to estradiol) was observed. In contrast, however, FSH priming signi®cantly increased the production of estradiol from both estrone and androstenedione. The former requires 17b-HSD type 1 activity and the latter aromatase and 17b-HSD type 1 if the conversion is via estrone, or 17b-HSD type 5 and aromatase if the conversion is via testosterone. Both type 1 and type 5 17b-HSD are present in the human ovary (Labrie et al., 2000) .
Others (Ghersevich et al., 1994a) have reported that in rat granulosa cells, rFSH stimulated expression and activity of 17b-HSD type 1, and subsequently it was shown that FSH induction of this enzyme was through a protein kinase A (PKA)-dependent pathway (Kaminiski et al., 1997) . In cultured human granulosa-luteal cells, gonadotrophins were shown to have no effect on 17b-HSD, although aromatase expression and activity was increased (Ghersevich et al., 1994b) . Interestingly, there is evidence of an ovarian de®ciency of the enzyme(s) in polycystic ovary syndrome (Toscano et al., 1990) .
It has generally been assumed that the action of aromatase on the conversion of testosterone to estradiol has been the major pathway through which estrogens are produced by granulosa cells. Recent studies have shown, however, that human type 5 17b-HSD, which converts androstenedione to testosterone, is expressed exclusively in thecal cells (Luu-The et al., 2001) . It was suggested that the production of estradiol in ovarian granulosa cells is preferentially via aromatization of 4-androstenedione to estrone and a subsequent conversion of estrone to estradiol by type 1 17b-HSD. This would be in agreement with the higher af®nity of aromatase for androstenedione compared with testosterone (Luu-The et al., 2001 ). The present studies certainly agree with this hypothesis, as the production of estradiol from precursors that involved the activity of type 1 17b-HSD generally produced higher concentrations of estradiol than testosterone alone (Figure 1 ). They also show that 17b-HSD type 1 in human GL cells can be modulated by FSH rather than aromatase, since the mean increase in estradiol production after FSH priming compared with control values was 16, 56 and 68% for testosterone, estrone and androstenedione respectively. This is consistent with the observations that FSH induction of aromatase is not generally observed in GL cells (see Lambert et al., 2000) . Whether or not type 5 17b-HSD is also modulated by FSH can neither be supported nor negated by this study.
Previous studies investigating the inhibitory effect of phytoestrogens on 17b-HSD or aromatase activity in placental microsomes or partially puri®ed or recombinant enzyme preparations show that the most potent phytoestrogens induce 50% inhibition of enzyme activity (IC 50 ) at concentrations in the range of 0.5 to 20 mmol/l. Thus, for these initial studies to screen the effects of phytoestrogens, a relatively high dose of 10 mmol/l was used. This is the same concentration of 4OH-A used to inhibit aromatase activity by competitively binding to the enzyme.
In human GL cells, 10 mmol/l apigenin had only weak inhibitory effects on enzyme activity, although after cells had been exposed to this phytoestrogen for 24 h there was a marked loss of both aromatase and 17b-HSD type 1 activity. In contrast, the other¯avone, quercetin was without effect on either enzyme. It has been reported (Ma Èkela È et al., 1995 (Ma Èkela È et al., , 1998 ) that 1.2 mmol/l apigenin inhibited the conversion of tritiated estrone to estradiol by~40% and 80% in a puri®ed 17b-HSD type 1 preparation and in T-47D breast cancer cells respectively, whilst quercetin at the same dose had no effect in either preparation. In human placental microsomes, apigenin was similarly shown to be a relatively potent inhibitor of 17b-HSD type 1 activity, with an IC 50 of 0.3 mmol/l (Le Bail et al., 1998) . Others (Krazeisen et al., 2001) showed that apigenin and quercetin were the most potent¯avones inhibiting the reductive activity of recombinant 17b-HSD type 5, with IC 50 values in the order of 20 mmol/l. With regard to the effects of avones on aromatase activity, apigenin has been reported to inhibit this enzyme, with an IC 50 of 2.9 mmol/l, in placental microsomes (Le Bail et al., 1998) and~5 mmol/l in partially puri®ed placental aromatase (Jeong et al., 1999) . Both apigenin and quercetin were found to be potent inhibitors of the aromatase enzyme complex from rainbow trout (Pelissero et al., 1996) , and quercetin was also found to inhibit aromatase activity in colorectal cancer cell lines (Fiorelli et al., 1999) .
Like apigenin, the iso¯avone genistein has also been reported to inhibit 17b-HSD type 1 activity (Le Bail et al., 1998; Whitehead et al., 2002) , whilst the effects of genistein and other iso¯avones on aromatase inhibition have generally been reported to be either weak or undetectable (Kao et al., 1998; Le Bail et al., 1998; Whitehead et al., 2002) .
In the present study, it was found that another iso¯avone, biochanin A, had no signi®cant effects on either 17b-HSD type 1 or aromatase, although others (Le Bail et al., 2000) reported that biochanin A inhibited human placental aromatase, 17b-HSD and 3b-HSD activities with IC 50 s of 49, 4.9 and 10 mmol/l respectively. Current investigations include the examination of dose±response curves to several phytoestrogens, and indeed someÐincluding biochanin AÐdo show a weak dose-related inhibition of aromatase in human GL cells. Compared with controls, however, signi®cance is only reached at a ten times higher dose (100 mmol/l) than those used in the present series of experiments.
The mycotoxin, zearalenone, showed potent effects on inhibiting the production of estradiol from androstenedione and testosterone, but had no effect on 17b-HSD type 1 activity converting estrone to estradiol. The latter result agrees with those of others (Ma Èkela È et al., 1995) on puri®ed 17b-HSD type 1. Interestingly, it has also been found (Krazeisen et al., 2001) that the ®ve most potent phytoestrogens inhibiting the reductive activity of 17b-HSD type 5 were zearalenone, coumestrol, quercetin, biochanin A and apigenin, with IC 50 s of 4, 5, 9, 14 and 20 mmol/l respectively.
The effects of the phytoestrogens investigated in the present study were not always in agreement with studies concerned with their effects on cell-free systems, or indeed with cancer cell lines (Ma Èkela È et al., 1998; Fiorelli et al., 1999) . One explanation is that the enzyme concentration/activity is very high in primary cultures of GL cells. Indeed, preliminary studies in our laboratory on MCF-7 cells have found that the production of estradiol/75 000 cells from the various substrates is ®ve to ten times lower after a 48 h period compared with that of human GL cells after a 4 h period.
In conclusion, these studies have established an experimental protocol for investigating the effects of phytoestrogens on enzyme activity in primary cultures of GL cells, and have shown that FSH primingÐin line with other studiesÐdid not induce aromatase in GL cells but did induce 17b-HSD type 1. In contrast with other studies there was no acute effect of phytoestrogens on enzyme activity but, when cells had been exposed to the compounds for 24 h and then exposed to steroid substrates for 4 h, inhibition of aromatase activity was observed. This suggests either that the lipid solubility of phytoestrogens is low and so permeation into the cells is slow, or that the compounds are being metabolized to inactive substances and/or the compounds and their metabolites are altering the expression, and hence concentration, of intracellular steroidogenic enzymes.
